WHO ICTRP trial
Can increased urine flow encouraged by the drug furosemide and increased water…
ISRCTN72194653 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN72194653 |
|---|---|
| Public title | Can increased urine flow encouraged by the drug furosemide and increased water intake prevent kidney injury caused by the contrast media used in angiography procedures in patients with reduced kidney function? |
| Scientific title | Contrast-Induced Nephropathy: Evaluation of MAtched hydration and furosemide in risky patients undergoing chronic total occlusion-percutaneous coronary intervention (CINEMA) |
| Primary sponsor | University of Sulaimani College of Medicine |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Iraq |
| Conditions | Prevention of contrast-induced nephropathy in patients with impaired renal function undergoing percutaneous coronary interventions for chronic total occlusion of the coronary arteries Urological and Genital Diseases |
| Interventions | After patients have agreed to take part in the study, those with baseline eGFR <60 ml/min/1.73 m2 will be randomly assigned to either control or treatment group. All patients will have a Foley catheter inserted. The treatment group will… |
| Registration date | Jul 23, 2019 |
| Target size | 998 |
| Secondary IDs | Nil known;Nil known |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: